H

Huakang Biomedical Holdings Co Ltd
HKEX:8622

Watchlist Manager
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Watchlist
Price: 0.184 HKD -0.54%
Market Cap: 92.1m HKD
Have any thoughts about
Huakang Biomedical Holdings Co Ltd?
Write Note

Gross Margin
Huakang Biomedical Holdings Co Ltd

65.4%
Current
65%
Average
47.4%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
65.4%
=
Gross Profit
16.4m
/
Revenue
25.1m

Gross Margin Across Competitors

Country HK
Market Cap 92.1m HKD
Gross Margin
65%
Country JP
Market Cap 7T JPY
Gross Margin
86%
Country CH
Market Cap 37.8B CHF
Gross Margin
55%
Country DK
Market Cap 205.9B DKK
Gross Margin
68%
Country US
Market Cap 16.6B USD
Gross Margin
70%
Country CN
Market Cap 52.9B CNY
Gross Margin
73%
Country CA
Market Cap 6.9B USD
Gross Margin
61%
Country UK
Market Cap 5.1B GBP
Gross Margin
56%
Country CH
Market Cap 5.2B CHF
Gross Margin
34%
Country US
Market Cap 5.9B USD
Gross Margin
47%
Country US
Market Cap 5.6B USD
Gross Margin
65%

Profitability Report

View the profitability report to see the full profitability analysis for Huakang Biomedical Holdings Co Ltd.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
65.4%
=
Gross Profit
16.4m
/
Revenue
25.1m
What is the Gross Margin of Huakang Biomedical Holdings Co Ltd?

Based on Huakang Biomedical Holdings Co Ltd's most recent financial statements, the company has Gross Margin of 65.4%.